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Benign lymphoepithelial lesion (BLEL) is also 
known as lymphoepithelial sialadenitis, 
lymphoepithelial lesion, myoepithelial sialadenitis, 
and Sjögren’s-type sialadenitis. It was first reported by 
Johann von Mikulicz-Radecki (1888) as synchronous 
inflammation of lacrimal and salivary glands [1]. 
Sjögren then referred to it as sicca syndrome, owing 
to salivary gland hyposecretion [1]. Goldwin first 
described the lymphoepithelial changes of BLEL in 
major salivary glands, presenting as unilateral or 
bilateral glandular enlargement without clinical signs 
of Sjögren’s syndrome [1]. However, Morgan and 
Castleman were the first to detail the histopathologic 
hallmarks of BLEL, namely marked 
lymphoplasmacytic infiltration with residual 
epimyoepithelial islands (punctuated by hyperplastic 
and metaplastic ducts) and acinar degeneration [1].
 In amyloidosis, insoluble polymeric protein fibrils 
are deposited in tissues and organs extracellularly. 
Secondary (AA) amyloidosis is characterized by 
accumulation of serum amyloid protein that is 
triggered in the setting of chronic inflammatory or 
infectious disease [2].  
 Reported here, with a review of the literature, is a 
patient with BLEL and secondary amyloidosis of the 
parotid gland as concurrent manifestations of 
Sjögren’s syndrome.
 A 51-year-old patient arrived at our facility with a 
left cheek mass (3 cm in diameter), which was firm, 
fixed, and non-tender, although eliciting related 
complaints of tightness and mild pain (Fig. 1). Upon 
assessment of facial features, mild, bilateral 
enlargement of lacrimal and submandibular glands 
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was evident, without palpable neck nodes. 
Computerized tomography (CT) of the neck (with 
contrast) showed diffuse swelling of both parotid 
glands, more so on left, where another ill-defined 
mass was present, raising suspicion of pleomorphic 
adenoma or carcinoma (Fig. 2). On this basis (and 
considering the duration of illness), conventional 
superficial parotidectomy was subsequently 
performed. Intraoperatively, the left-sided mass was 
near rupture, with dense periglandular adhesions and 
two enlarged nearby lymph nodes. Microscopic 
examination showed that ductal and acinar elements 
were heavily infiltrated by benign lymphoid cells, and 
discrete germinal centers were visible, all leading to a 
diagnosis of BLEL (Fig. 3A). Considerable 
parenchymal deposition of amorphous eosinophilic 
material was also seen (Fig. 3B). The latter displayed 
the characteristic apple-green birefringence of 
amyloid on Congo red stain.
 Due to claims of mild eye and mouth dryness in 
the 3 months prior to this visit, diagnostics and 
treatment for potential Sjögren’s syndrome were 
initiated postoperatively. Salivary gland scintigraphy 
showed very low radionuclide uptake by parotid and 
submandibular glands bilaterally (Fig. 4). Laboratory 
indices were positive for rheumatoid factor, anti-
nuclear antibody, anti-Sjörgen’s-syndrome-related 
antigen A (anti-SSA, anti-Ro), and anti-Sjörgen’s-
syndrome-related antigen B (anti-SSA, anti-La). 
Serum levels of immunoglobulin G (IgG) (2,220 
mg/dL) and immunoglobulin A (IgA) (476 mg/dL) 
were elevated, but immunoglobulin M (IgM) (121 
mg/dL) and IgG4 immunoglobulin fractions (87.9 
mg/dL; reference range, 39.2–894.0 mg/dL) were 
within normal ranges. Results of Schirmer’s test (left, 
9 mm; right, 30 mm) and break-up time scores (left, 
2 sec; right, 4 sec) were low. As suspected, the 
patient’s profile fulfilled revised international 
classification criteria for Sjögren’s syndrome [3]. 
 Following surgery, the patient was given 
pilocarpine eye drops for treatment of dry eyes. 
Other than mild residual hollowing of the left cheek, 
she suffered no true complications during a one-year 
follow-up period, and she refused recommended 
monitoring (ultrasonography or computed 
tomography) to check for recurrence. 
 BLEL is considered an autoimmune disease of 
salivary glands. Clinical features of Sjögren’s 
syndrome may be manifested by 50% to 84% of 
patients with BLEL, which increases the risk (40:1) 
Fig. 2.  
Contrast-enhanced computed 
tomography of neck: note 
bilateral diffuse swelling of 
parotid glands, more so on 
left; greater enhancement 
accentuates irregularly shaped 
3-cm mass of left parotid 
gland, which proved to be 
amyloid.
Fig. 3.  
Microscopic views (H&E stain) 
of parotid gland mass: (A) 
obliteration of ducts and acini 
by benign lymphoid infiltrates 
forming germinal centers 
(200×); (B) considerable 
parenchymal deposition 
of amorphous eosinophilic 
material, later confirmed as 
amyloid on Congo red stain 
(200×). A B
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of developing malignant lymphoma, especially in 
long-standing BLEL. Hence, follow-up surveillance 
for potential malignant transformation is advised [4].
 Amyloid is seen as eosinophilic fibrils in 
hematoxylin and eosin (H&E)-stained tissue; and on 
Congo red stain, its regularly structured β-pleated 
sheets result in a unique apple-green birefringence 
under light microscopic polarization. AA amyloidosis 
is typically associated with chronic inflammatory 
disease and may be confirmed via 
immunohistochemistry [2].
 In patients with salivary gland enlargement, 
diagnosis of BLEL may be difficult due to the many 
benign inflammatory conditions that arise and/or the 
occurrence of salivary cysts or tumors. For differential 
diagnostic purposes, imaging modalities such as CT, 
ultrasound, technetium scan, and sialography may be 
helpful, although such technical advancements are 
not routinely utilized in the management of salivary 
gland tumors. Fine needle aspiration biopsy is 
controversial in this setting, because for many 
surgeons, the presence of tumor alone is sufficient 
indication to operate. With a sensitivity near 90% and 
a specificity of 75%, fine needle aspiration (FNA) 
biopsy may have a role in documenting the benign 
disease of poor-risk patients, thus avoiding 
inappropriate surgery [5]. Nevertheless, histologic 
findings may be precarious. A history of autoimmune 
disease or complaints of dry eyes or mouth often are 
diagnostic clues, given a heterogeneous lymphoid 
component. Grounds for diagnosis of BLEL by FNA 
include the presence of epimyoepithelial islands, 
numerous small lymphocytes, and a granular 
proteinaceous background [5].
 Concurrent BLEL and secondary amyloidosis 
affecting parotid gland unilaterally have not been 
reported to date. In this instance, the irregularly 
contoured margins of accumulated amyloid and the 
dense periglandular adhesions observed, both 
induced by inflammation, are easily interpreted 
radiographically and grossly as signs of pleomorphic 
adenoma or features of malignancy. Because BLEL 
may be a consequence of human immunodeficiency 
virus infection or may progress to Hodgkin’s 
lymphoma, history-taking is critical, and lumpectomy 
may be beneficial [5]. Surgical removal of such 
tumors is often tempting to exclude malignancy, but 
various radiologic modalities and/or FNA biopsy do 
have merit in this context, utilizing a multidisciplinary 
approach (i.e., rheumatologist, pathologist, and 
ophthalmologist) to establish a diagnosis and 
determine appropriate treatment. In a patient with 
documented autoimmune disease, the differential 
diagnosis of a cheek mass should include benign 
systemic conditions. As seen here, focal deposition of 
amyloid in BLEL may mimic pleomorphic adenoma 
or malignancy of the parotid gland. 
Fig. 4. 
Scan of salivary glands: 
markedly diminished uptake of 
radionucleotide in both parotid 
and submandibular glands, 
relative to thyroid gland.
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Soft tissue chondroma is a rare benign tumor, and it 
mainly affects hands and feet. Its prevalence reaches 
the highest level in individuals aged between 30 years 
and 60 years. In addition, it is known that there is no 
sex-related difference in its incidence. Repeated 
microtrauma has also been reported to be responsible 
for its occurrence. 
 A 72-year-old woman visited us with a chief 
complaint of a 3-year-history of a palpable, skin 
protuberance on the left third toe. The patient had a 
past history of taking surgical excision for skin 
protuberance at the department of dermatology of 
other hospital. Thereafter, however, the patient 
received resection of the skin protuberance again 
because of its recurrence. Nevertheless, the patient 
had a palpable mass at the surgical sites and 
complained about discomfort in the toe. Therefore, 
the patient visited us. On physical examination, the 
patient had a round, ill-defined skin protuberance 
with a diameter of approximately 1 cm. On palpation, 
it was a rather solid mass. In addition, the patient had 
a scratch on the skin surface (Fig. 1). On preoperative 
plain radiography, the patient had a calcified lesion 
with a diameter of < 1 mm in the deep lesion of the 
skin mass (Fig. 2). 
 After IV sedation, local anesthesia is applied and 
then the patient received a resection of the mass. We 
made an oval-shaped incision along the margin of the 
skin protuberance, for which we set the depth of 
resection at the right above the periosteum, thus 
attempting to sufficiently involve the subcutaneous 
adipose tissue. Thus, we performed a resection of the 
mass involving the calcified lesion identified on 
preoperative plain radiography. Postoperatively, the 
size of the resected mass was 1.0 × 0.8 cm. We 
performed histopathologic examinations (Fig. 3).
 On histopathologic examinations, the patient was 
diagnosed with chondroma characterized by the 
Fig. 1.  
Preoperative clinical view. 
72-year-old female patients 
visited our hospital with chief 
complaint of 1 cm sized round 
and protuberance skin lesion 
which had a indeterminated 
margin on dorsolateral aspect 
of third toe on left foot. 
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